In the present study, GRS in the subgroup of stage IV patient showed the notable ability to help clinical factors to distinguish more patients with better and worse survival in a dynamic process (Cindex, 0.68 vs 0.62), although the result did not reach statistical significance ( P = 0.417).
← all excerpts
Is there a dose-dependent effect of genetic susceptibility loci for gastric cancer on prognosis of the patients?
1
0.4170
0.4170